Tratamiento del carcinoma broncogénico de célula no pequeña en estadios precoces

José Carlos Meneses; Régulo J. Ávila Martínez; Santiago Ponce; Mauricio Zuluaga; Adela Bartolomé; Pablo Gámez

doi:10.1016/j.ciresp.2013.01.007

Tratamiento del carcinoma broncogénico de célula no pequeña en estadios precoces

Translated title of the contribution: Treatment of non-small cell lung carcinoma in early stages

José Carlos Meneses, Régulo J. Ávila Martínez, Santiago Ponce, Mauricio Zuluaga, Adela Bartolomé, Pablo Gámez

Research output: Contribution to journal › Short survey › peer-review

Abstract

Treatment of lung carcinoma is multidisciplinary. There are different therapeutic strategies available, although surgery shows the best results in those patients with lung carcinoma in early stages. Other options such as stereotactic radiation therapy are relegated to patients with small tumors and poor cardiopulmonary reserve or to those who reject surgery. Adjuvant chemotherapy is not justified in patients with stage i of the disease and so double adjuvant chemotherapy should be considered. This adjuvant chemotherapy should be based on cisplatin after surgery in those patients with stages ii and IIIA.

Translated title of the contribution	Treatment of non-small cell lung carcinoma in early stages
Original language	French
Pages (from-to)	625-632
Number of pages	8
Journal	Cirugia Espanola
Volume	91
Issue number	10
DOIs	https://doi.org/10.1016/j.ciresp.2013.01.007
Publication status	Published - 1 Dec 2013
Externally published	Yes

Access to Document

10.1016/j.ciresp.2013.01.007

Cite this

@article{356b7fb1141845e387da1d26b8cc853d,

title = "Tratamiento del carcinoma broncog{\'e}nico de c{\'e}lula no peque{\~n}a en estadios precoces",

abstract = "Treatment of lung carcinoma is multidisciplinary. There are different therapeutic strategies available, although surgery shows the best results in those patients with lung carcinoma in early stages. Other options such as stereotactic radiation therapy are relegated to patients with small tumors and poor cardiopulmonary reserve or to those who reject surgery. Adjuvant chemotherapy is not justified in patients with stage i of the disease and so double adjuvant chemotherapy should be considered. This adjuvant chemotherapy should be based on cisplatin after surgery in those patients with stages ii and IIIA.",

keywords = "Early stages, Lung cancer, Non-small cell",

author = "Meneses, {Jos{\'e} Carlos} and {{\'A}vila Mart{\'i}nez}, {R{\'e}gulo J.} and Santiago Ponce and Mauricio Zuluaga and Adela Bartolom{\'e} and Pablo G{\'a}mez",

year = "2013",

month = dec,

day = "1",

doi = "10.1016/j.ciresp.2013.01.007",

language = "Fran{\c c}ais",

volume = "91",

pages = "625--632",

journal = "Cirugia Espanola",

issn = "0009-739X",

number = "10",

}

TY - JOUR

T1 - Tratamiento del carcinoma broncogénico de célula no pequeña en estadios precoces

AU - Meneses, José Carlos

AU - Ávila Martínez, Régulo J.

AU - Ponce, Santiago

AU - Zuluaga, Mauricio

AU - Bartolomé, Adela

AU - Gámez, Pablo

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Treatment of lung carcinoma is multidisciplinary. There are different therapeutic strategies available, although surgery shows the best results in those patients with lung carcinoma in early stages. Other options such as stereotactic radiation therapy are relegated to patients with small tumors and poor cardiopulmonary reserve or to those who reject surgery. Adjuvant chemotherapy is not justified in patients with stage i of the disease and so double adjuvant chemotherapy should be considered. This adjuvant chemotherapy should be based on cisplatin after surgery in those patients with stages ii and IIIA.

AB - Treatment of lung carcinoma is multidisciplinary. There are different therapeutic strategies available, although surgery shows the best results in those patients with lung carcinoma in early stages. Other options such as stereotactic radiation therapy are relegated to patients with small tumors and poor cardiopulmonary reserve or to those who reject surgery. Adjuvant chemotherapy is not justified in patients with stage i of the disease and so double adjuvant chemotherapy should be considered. This adjuvant chemotherapy should be based on cisplatin after surgery in those patients with stages ii and IIIA.

KW - Early stages

KW - Lung cancer

KW - Non-small cell

UR - http://www.scopus.com/inward/record.url?scp=84888833077&partnerID=8YFLogxK

U2 - 10.1016/j.ciresp.2013.01.007

DO - 10.1016/j.ciresp.2013.01.007

M3 - Brève enquête

C2 - 23829961

AN - SCOPUS:84888833077

SN - 0009-739X

VL - 91

SP - 625

EP - 632

JO - Cirugia Espanola

JF - Cirugia Espanola

IS - 10

ER -

Tratamiento del carcinoma broncogénico de célula no pequeña en estadios precoces

Abstract

Access to Document

Other files and links

Cite this